secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axe Compute Inc. (AGPU)
CIK:        0001446159
Form:       8-K
Filed at:   2024-08-14T23:59:59+00:00
Accession:  0001171843-24-004775
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Predictive Oncology Q2 net loss $3.2M on revenue $0.3M; enters biomarker discovery market
--------------------------------------------------------------------------------

- Net loss of $3.2M ($0.68 per share) on revenue of $278,722, down 43% YoY from $490K.
- Cash and equivalents $5.3M at June 30, 2024; raised $3.1M net from ATM and $1.3M post-quarter from warrants.
- Entering biomarker discovery market after successful ovarian cancer study with UPMC; market estimated at $51.5B.
- Cost savings initiative to cut cash used in operations by ~20% annually, consolidating Birmingham lab into Pittsburgh.
- Gross margin fell to 45% from 67% due to higher labor costs and lower STREAMWAY system sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446159/000117184324004775/0001171843-24-004775-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446159/000117184324004775/f8k_081324.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-004775

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer